ISHARES TR's ticker is IBB and the CUSIP is 464287556. A total of 852 filers reported holding ISHARES TR in Q2 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $57,000 | -14.9% | 441 | 0.0% | 0.02% | -14.3% |
| Q4 2021 | $67,000 | -5.6% | 441 | 0.0% | 0.02% | -12.5% |
| Q3 2021 | $71,000 | -1.4% | 441 | 0.0% | 0.02% | -4.0% |
| Q2 2021 | $72,000 | +9.1% | 441 | 0.0% | 0.02% | -3.8% |
| Q1 2021 | $66,000 | -1.5% | 441 | 0.0% | 0.03% | -13.3% |
| Q4 2020 | $67,000 | +11.7% | 441 | 0.0% | 0.03% | 0.0% |
| Q3 2020 | $60,000 | -40.6% | 441 | -40.5% | 0.03% | -44.4% |
| Q2 2020 | $101,000 | +26.2% | 741 | 0.0% | 0.05% | +1.9% |
| Q1 2020 | $80,000 | -10.1% | 741 | 0.0% | 0.05% | +6.0% |
| Q4 2019 | $89,000 | +20.3% | 741 | 0.0% | 0.05% | +11.1% |
| Q3 2019 | $74,000 | -8.6% | 741 | 0.0% | 0.04% | -8.2% |
| Q2 2019 | $81,000 | -2.4% | 741 | 0.0% | 0.05% | -7.5% |
| Q1 2019 | $83,000 | +16.9% | 741 | 0.0% | 0.05% | +3.9% |
| Q4 2018 | $71,000 | -16.5% | 741 | 0.0% | 0.05% | -10.5% |
| Q3 2018 | $85,000 | +4.9% | 741 | 0.0% | 0.06% | -5.0% |
| Q2 2018 | $81,000 | -31.9% | 741 | -33.6% | 0.06% | -33.3% |
| Q1 2018 | $119,000 | – | 1,116 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atom Investors LP | 78,501 | $10,139,189 | 5.52% |
| Bronte Capital Management Pty Ltd. | 302,076 | $39,016,136 | 4.53% |
| Michelson Medical Research Foundation, Inc. | 43,395 | $5,604,898 | 4.40% |
| Hackensack Meridian Health, Inc. | 228,000 | $29,448,480 | 4.26% |
| DAFNA Capital Management LLC | 102,500 | $13,238,900 | 3.97% |
| Richmond Brothers, Inc. | 16,724 | $2,159,856 | 3.64% |
| Alpha Family Trust | 34,549 | $4,462,349 | 3.53% |
| HANSEATIC MANAGEMENT SERVICES INC | 11,897 | $1,537 | 3.46% |
| PURSUE WEALTH PARTNERS LLC | 37,789 | $4,880,827 | 3.33% |
| Rye Brook Capital LLC | 40,100 | $5,179 | 3.17% |